• Otonomy's resurrected ear drug is now dead again - and investors aren't hanging around

    8 days ago - By San Diego Biotechnology

    More than three years after it was raised from the dead, Otonomy's lead drug appears headed to the scrap heap for good.
    The drug, Otividex, failed to beat placebo at reducing definitive vertigo days for the intent-to-treat population of patients with M......
    Read more ...